The Cigna Group (CI)
Why Cigna (CI) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Cigna Group (CI) Q4 2025 Earnings Call Transcript
The Cigna Group (CI) Q4 2025 Earnings Call Transcript
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes
CI's Q4 adjusted EPS beats estimates as Evernorth growth and higher specialty volumes offset fewer medical customers and elevated costs.
Make Your Portfolio Healthy Again: The Cigna Group
The Cigna Group stands out as a deeply undervalued healthcare pick, trading at a forward P/E of 9 versus a 10-year average of 13.5. CI targets 10–14% annual adjusted EPS growth long-term, driven by customer growth, pricing, acquisitions, and share repurchases. The stock offers a 2.2% dividend yield with a low payout ratio, supporting continued double-digit dividend growth and a Chowder number near 13.
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cigna (CI) Q4 Earnings and Revenues Beat Estimates
Cigna (CI) came out with quarterly earnings of $8.08 per share, beating the Zacks Consensus Estimate of $7.87 per share. This compares to earnings of $6.64 per share a year ago.
Cigna Revenue Lifted by Growth in its Evernorth Unit
Cigna Group logged higher revenue in its latest quarter as its pharmacy-benefit business Evernorth continues to grow.
Cigna 2025 Profits Hit Nearly $6 Billion Even As Costs Keep Rising
The Cigna Group Thursday reported 2025 net income of nearly $6 billion despite grappling with rising costs of patients in the health insurance plans it sells and administers.
Will Declining Medical Customers Affect Cigna's Q4 Earnings?
CI heads into Q4 earnings with rising Evernorth revenues but falling premiums and medical customers, raising questions about the quarter's overall growth outlook.
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q4 Earnings
Besides Wall Street's top-and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Cigna Shares on the Couch: Time to Stay Strong or Walk Away Now?
CI looks worth holding as Evernorth growth, expanding pharmacy services, cheap valuation and shareholder returns support its long-term outlook.
